Stock Track | Hua Medicine-B Soars 5.14% Intraday on Strong 2025 Earnings and Record Profitability

Stock Track

03/27

Hua Medicine-B's stock soared 5.14% during intraday trading on Friday, following the release of its impressive 2025 financial results.

The surge comes after the company announced a historic breakthrough into profitability, with an annual profit of RMB1.11 billion. Its core diabetes drug, dorzagliatin, saw sales volume jump 91% to over 4 million boxes, driving net sales up 93% to RMB 492.9 million. Gross profit surged 125% to RMB 280.4 million, with the margin improving significantly.

Investor sentiment was further buoyed by news of the drug's successful market expansion, including approval in Hong Kong, and the company's optimistic outlook for continued growth and pipeline development in the global diabetes treatment field.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/1137662369"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1137662369\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1137662369?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-27 09:37","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1137662369","market":"nz","top_or_hot":-1,"title":"Stock Track | Hua Medicine-B Soars 5.14% Intraday on Strong 2025 Earnings and Record Profitability","media":"Stock Track","content":"<p>Hua Medicine-B's stock soared 5.14% during intraday trading on Friday, following the release of its impressive 2025 financial results.</p><p>The surge comes after the company announced a historic breakthrough into profitability, with an annual profit of RMB1.11 billion. Its core diabetes drug, dorzagliatin, saw sales volume jump 91% to over 4 million boxes, driving net sales up 93% to RMB 492.9 million. Gross profit surged 125% to RMB 280.4 million, with the margin improving significantly.</p><p>Investor sentiment was further buoyed by news of the drug's successful market expansion, including approval in Hong Kong, and the company's optimistic outlook for continued growth and pipeline development in the global diabetes treatment field.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Hua Medicine-B Soars 5.14% Intraday on Strong 2025 Earnings and Record Profitability</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Hua Medicine-B Soars 5.14% Intraday on Strong 2025 Earnings and Record Profitability\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time smaller\">2026-03-27 09:37</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Hua Medicine-B's stock soared 5.14% during intraday trading on Friday, following the release of its impressive 2025 financial results.</p><p>The surge comes after the company announced a historic breakthrough into profitability, with an annual profit of RMB1.11 billion. Its core diabetes drug, dorzagliatin, saw sales volume jump 91% to over 4 million boxes, driving net sales up 93% to RMB 492.9 million. Gross profit surged 125% to RMB 280.4 million, with the margin improving significantly.</p><p>Investor sentiment was further buoyed by news of the drug's successful market expansion, including approval in Hong Kong, and the company's optimistic outlook for continued growth and pipeline development in the global diabetes treatment field.</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02552","symbol_name":"華領醫藥-B","start_time":0,"source_url":"","article_id":"1137662369","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1137662369","pubTimestamp":1774575455,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Hua Medicine-B's stock soared 5.14% during intraday trading on Friday, following the release of its impressive 2025 financial results.The surge comes after the company announced a historic...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02552":"华领医药-B"},"translate_title":"个股赛道|华领医药-B盘中大涨5.14%2025年盈利强劲盈利创纪录","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02552":1},"content_text":"Hua Medicine-B's stock soared 5.14% during intraday trading on Friday, following the release of its impressive 2025 financial results.The surge comes after the company announced a historic breakthrough into profitability, with an annual profit of RMB1.11 billion. Its core diabetes drug, dorzagliatin, saw sales volume jump 91% to over 4 million boxes, driving net sales up 93% to RMB 492.9 million. Gross profit surged 125% to RMB 280.4 million, with the margin improving significantly.Investor sentiment was further buoyed by news of the drug's successful market expansion, including approval in Hong Kong, and the company's optimistic outlook for continued growth and pipeline development in the global diabetes treatment field.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"2","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}